CRIS
Curis Inc

13,627
Loading...
Loading...
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
34

Frequently Asked Questions

What is Market Cap of Curis Inc?
What is the 52-week high for Curis Inc?
What is the 52-week low for Curis Inc?
What is Curis Inc stock price today?
What was Curis Inc stock price yesterday?
What is the PE ratio of Curis Inc?
What is the Price-to-Book ratio of Curis Inc?
What is the 50-day moving average of Curis Inc?
How many employess does Curis Inc has?

Latest CRIS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.